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Abstract
Despite all recent efforts, cancer of the uterine cervix still remains one of the most frequent malignancies among women.  Lymphatic vessels represent 
the primary route of tumor cells dissemination in cervical cancer.  It has been demonstrated that cervical neoplasia actively participates in the recruitment 
of new blood and lymphatic vessels.  Macrophages are extremely versatile cells which have a significant contribution to tumor progression.  The aim: 1) 
To establish the correlation between tumor-associated macrophages (TAM) and the grade of the uterine cervix neoplasia; 2) To evaluate the distribution 
of TAM within both intratumoral and peritumoral areas.  Material and Methods: Ninety-six cases were studied.  The specimens were fixed in buffered 
formalin and paraffin embedded.  Step sections, 5µm thick, were performed for each case. Initial sections were stained with haematoxylin-eosin, for 
the pathological diagnosis and grading of the tumor.  Lesions were classified as follows: squamous cell metaplasia (n = 12), CIN I (n = 8), CIN II (n = 
6), CIN III (n = 24), microinvasive carcinoma (n = 16) and invasive squamous cell carcinoma (n = 26).  Additional sections for each case were stained 
for CD68 antibody, in order to highlight the macrophages.  Quantification of macrophage population has been made based on hot-spot technique.  The 
arithmetic media of 3 (× 200) fields represented the final result.  Results: We found a statistical correlation between peritumoral macrophages (PTM) 
and intratumoral macrophages in all stages of cervical neoplasia, macrophage density and tumor stage (p = 0.01).  In 16 cases we found vascular invasion. 
Almost in all these cases (87.5%) intravascular tumor emboli were embedded with CD68+ cells.  Conclusions: based on these findings, we consider that 
macrophages are key regulators of cervical cancer progression.  TAM targeted management could be an essential therapeutic strategy, not only in order 
to suppress the progression of cervical neoplasia, but also to inhibit macrophage-mediated vascular invasion.
Key words: uterine cervix cancer, macrophages, cellular density, tumor progression, CD68.
Корреляция плотности макрофагов с тяжестью неоплазии шейки матки
Рак шейки матки остается одной из самых часто встречающихся злокачественных заболеваний женского населения.  Лимфатические 
сосуды являются первичным путем метастазирования при данном заболевании.  Было доказано, что клетки цервикальной неоплазии активно 
участвуют в образовании новых лимфатических сосудов.  Макрофаги – многофункциональные клетки, оказывающие большое влияние 
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на прогрессирование опухоли.  Цель: 1). Выявление корреляции между макрофагами и стадией прогрессии неоплазии шейки матки; 2). 
Определение особенностей распределения макрофагов внутри опухолевой массы и вокруг нее.  Материал и методы.  Было изучено 96 случаев. 
Материал фиксировали в формалине с последующим заключением в парафин.  Для каждого случая производили срезы, толщиной в 5 мкм. 
Изначально, срезы окрашивали гематоксилин-эозином для определения гистопатологического диагноза.  Были получены следующие группы 
поражений: плоскоклеточная метаплазия (n = 12), CIN I (n = 8), CIN II (n = 6), CIN III (n = 24), микрокарцинома (n = 16), инвазивный рак (n = 
26).  Для выявления макрофагов, произвoдили иммуногистохимическое исследование с использованием маркера CD68.  Подсчет популяции 
макрофагов производили по методике hot-spot.  Результаты. Мы получили статистически значимую корреляцию между внутритуморальными 
и перитуморальными макрофагами во всех стадиях прогрессии неоплазии шейки матки, между плотностью макрофагов и стадией опухоли (p 
= 0,01).  В 16 случаях выявили сосудистые эмболы.  Почти во всех случаях (87,5%) внутрисосудистые эмболы содержали в себе CD68+ клетки. 
Выводы: Основываясь на полученных результатах, мы считаем, что макрофаги вовлечены в прогрессию рака шейки матки.
Ключевые слова: рак шейки матки, макрофаги, клеточная плотность, опухолевая прогрессия, CD68.
Introduction
The crucial importance of the HPV infection in the deve-
lopment of cervical cancer was well established in the middle 
of the ’90s.  Based on this evidence, strategies were developed, 
mainly focused on the prevention of this disease, which led to 
the dramatic decreasing of its incidence.  Despite on the facts 
named above, cervical cancer still remains one of the most 
frequent neoplasia for women.
Cancer progression is a complex biological phenomenon, 
characterized by a multitude of intrinsic and extrinsic events, 
such as: the blocking of negative signals, the enhancing of 
positive signals, the over-expression of membrane receptors 
for pro-tumor growth factors, the promotion of cellular mo-
tility, and the recruitment of new blood vessels and new LV.
The ability of cancer cells to migrate from the primary 
tumor and to give rise to new cellular colonies at the distant 
sites influences tumor grading, therapeutic management, 
patient’s survival.  The lymphatic way of metastasizing involves 
the regional lymph nodes (RLN), and represents an important 
criterion of the poor prognosis.
Tumor progression can not be supported only by the tumor 
cells’ related molecular factors.  A great importance in cancer 
development is played by the cells from tumor microenviron-
ment (fibroblasts, myofibroblasts, mast cells, macrophages) 
[1].  Nowadays the mutual inducing mechanisms between 
tumor cells and stromal cells are well known.  The fact that 
tumor inflammatory infiltrate (TII) correlates with cancer’s 
progression is widely accepted [2].  Macrophages are extremely 
versatile and are one the most numerous cell populations in 
the TII.  In addition to a large number of pro-tumor factors, 
synthesized by the tumor-associated macrophages (TAM), 
it has been established that these cells produce significant 
amounts of VEGF-C, which is one important lymphangio-
genic factor, as well as VEGF-D.
The pro-tumoral role of TAM in human cancers is sup-
ported by many clinical studies that found a correlation be-
tween high macrophage density and poor patient prognosis. 
Many macrophage products released in the tumor stroma 
can directly stimulate the growth and promote the tumor 
cell migration and metastasis.  Among the molecular factors 
that mediate these effects are epidermal growth factor (EGF), 
transforming growth factor β (TGF β), vascular endothelial 
growth factor (VEGF), cytokines, chemokines.
The aim was: 1) To establish the role of TAM in lymphan-
giogenesis; 2) To evaluate correlation between TAM density 
and the stage of cervical neoplasia progression; 3) To assess 
the involvement of TAM in vascular invasion.
Material and methods
Targeted biopsies taken from conization were investigated, 
at Institute of Oncology from Republic of Moldova between 
June 2008 and May 2009, in patients with macroscopically 
detectable cervical lesions.  The specimens were fixed in 
buffered formalin and paraffin embedded. Step sections, 
5µm thick, were performed for each case.  Initial sections 
were stained with haematoxylin-eosin, for the pathological 
diagnosis and grading of the tumor.  Lesions were classified 
as follows: squamous cell metaplasia (n = 12), CIN I (n = 8), 
CIN II (n = 6), CIN III (n = 24) 17 CIN III and 7 CIS mi-
croinvasive carcinoma (n = 16) and invasive carcinoma (n = 
26).  Additional sections for each case were stained for CD68, 
with LSAB+ technique, using Avidin-Biotin working system. 
Antigen retrieval was done by microwave oven heating in 
retrieval solution pH6 (Dako Cytomation).  Incubation of 
primary antibody was for 30 minutes.  Identification of pri-
mary antibody we performed with DAB chromogen (Dako 
Denmark).  Quantification of macrophage population has 
been made in accordance with hot-spot technique.  The 
arithmetic media of 3 (×200) fields represented the final 
result.  For nuclei counterstaining, we used Lille’s modified 
Hematoxylin. Images were taken using a Nikon Eclipse 
(E600) camera.  The entire immunohistochemical analysis 
was performed on autostainer (Dako Cytomation).
Results
Squamous metaplasia
Morphologically, macrophages were small with cytoplas-
matic pattern of immunostaining.  The density of PTM ranged 
between 73 and 90, with an average of 85.2.  The values of ITM 
ranged between 16 and 23, with an average of 21.2.
CIN I and CIN II.
PTM were placed mainly in lamina propria.  ITM were big-
ger, placed in all layers of the epithelium, with higher density 
in the basal, parabasal and intermediate layers.  Statistically 
significant correlation was found between stromal macro-
phage and intraepithelial macrophage densities (p = 0.044).
CIN III.
PTM ranged between 149 and 312, with an average of 
124.4.  Intratumoral macrophages were distributed in all 
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layers, with a slight increased density in the basal 1/3 of the 
squamous epithelium (fig. 1).
The lowest density of ITM was 51, the highest – 144, 
the mean – 103.7.  A statistically significant correlation was 
found between peritumoral macrophages and intratumoral 
macrophages (0.015).
Microinvasive and invasive cancer
PTM ranged between 165 and 416, with an average of 
298.6.  ITM were big with an evident tendency to form clusters 
and with less intensity of the CD68 expression in comparison 
with PTM.  They were ranged between 109 and 310, with 
an average of 200.  Correlation between PTM and ITM was 
significant (p = 0.001).
In invasive carcinoma, PTM were placed diffuse in peri-
tumoral stroma, mainly around vessels and were organized 
in groups (fig. 2).
PTM ranged between 219 and 617, with an average of 413.6. 
ITM were also diffused inside the whole tumor mass (fig. 3).
We observed a tendency of macrophages to fuse and form 
big multinucleated cells.  This phenomenon was found by 
us only in invasive carcinoma within epithelial tumor mass 
(fig.3).
Cells were significantly bigger than PTM, while the in-
tensity of expression often was lower.  The highest ITM den-
sity was 522, the lowest -189, the mean – 322.8.  Significant 
correlation was found between PTM and ITM (p = 0.012). 
We have found no correlation between both PTM and ITM 
densities and vascular invasion.
Vascular invasion
We have found vascular invasion in 16 of 26 cases of 
invasive carcinoma.  Almost all emboli from invaded vessels 
contained CD68+ macrophages (fig. 5).
In 22 cases (84.61%) we detected intercalated CD68+ cells 
among the endothelial cells of vessels (fig. 6).
Fig. 1.  Cervical Intraepithelial Neoplasia III (x100).  
Macrophages are located in all layers of stratified 
squamous epithelium, with a slight increasing of their 
density in basal and parabasal layers. Fig. 2.  Invasive carcinoma (x200).  Peritumoral 
macrophages placed around vascular structure.
Fig. 3.  Invasive carcinoma (x400). Diffuse distribution 
of tumor associated macrophages within peritumoral 
stroma.
Fig. 4.  Invasive carcinoma (x400). Multinucleated CD68+ 
cluster inside the tumor mass.
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Discussions
It is well known that macrophages are one the most 
versatile cells [3].  There is an increasing body of evidence 
that proves that macrophages represent a key regulator in 
progression of different human solid tumors.  Linear in-
creasing of both, ITM and PTM densities, from pre-invasive 
to invasive cervical lesions, detected in our study, strongly 
indicates on catalytic function of these cells in cervical 
carcinogenesis.  The same results have been reported before 
[4].  It is well known that macrophages have the ability to 
proliferate.  This phenomenon was described in detail in 
wound healing and glomerulonephritis [5], while, in recent 
literature there are few data about macrophage proliferation 
in tumors.  It seems to be clear about the origin of PTM. 
Tumor cells produce a broad spectrum of cytokines and 
growth factors which are chemoatractants for macrophage 
precursor cells and lead to their accumulation into the 
stroma of peritumoral area, and further differentiation 
into adult macrophages.  It is supposed that ITM have a 
dual origin: intratumoral migration of periepithelial ma-
crophages and their local proliferation.  Based on the fact 
that in all groups of lesions PTM density was higher than 
ITM, and on the statistical correlation found between them, 
we suggest that ITM population is mainly provided by the 
PTM invasion into the tumor mass.
There is a big amount of evidences (experimental and 
clinical) that proved without any doubts the TAM’s role in 
cancer-cell spreading.  This role is mediated by a variety of 
pathogenic chains, orchestrated by TAM.  On one hand, ma-
crophages determine the cancer cells mobility, through EGF 
secretion, and stromal invasion, by extracellular matrix remo-
deling.  On the other hand, macrophages are actively involved 
in tumor-derived angiogenesis and lymphangiogenesis.  As a 
result, detaching of neoplastic cell, from its primary locus, and 
vessel penetrating is much easier.  Presence of CD68+ cells 
almost in all intravascular emboli, obtained by us, underpin 
these statements.
There is an increasing body of evidence that macrophages 
are actively involved in LAG [6].  There is a dual mechanism 
of LAG promoted by macrophages: macrophage transdiffe-
rentiation into the LEC, and synthesis of VEGF-C.
Cervical carcinogenesis consists of several well-distinguis-
hed stages: CIN, carcinoma in situ, microcarcinoma, invasive 
carcinoma.  It has been reported that potent lymphangiogenic 
switch occurs in high-grade CIN stage [7].  LAG is dependent 
on LEC proliferation. VEGF-C (vascular endothelial growth 
factor C) is the main mitogenic factor which controls this 
proliferation.  It has been demonstrated that macrophages 
represent an important source of VEGF-C.  Macrophage 
Table 1
Type of cervical 
lesion
MS  
(n = 12)
CIN I 
(n = 8)
CIN II  
(n = 6)
CIN III  
(n = 24)
Microinvasive 
Carcinoma
(n = 16)
Invasive  
Carcinoma
(n = 26)
PT M 85.2 106.38 118.14 124.4 298.6 413.6
IT M 21.2 56.88 84 103.7 200 322.8
Fig. 5.  Invasive carcinoma (x200). Intravascular tumor 
embolus embedded with macrophages.
Fig. 6.  Invasive carcinoma (x400).  Flattened, CD68+ cells, 
intercalated between endothelial cells of invaded vessel.
precursors express VEGFR-3, transmembrane receptor which 
transduce VEGF-C signals.  It has been shown that VEGF-
C, produced by tumor cells, interacts with VEGFR-3, from 
membrane of macrophage precursors, and determines their 
recruitment [8].  Once these cells reach to the peritumoral 
area, they begin to secrete own VEGF-C, which enhance the 
macrophage recruitment and also interact with VEGFR-3 on 
LEC.  On the other hand, macrophages are able to transdiffe-
rentiate into LEC and to integrate into sprouting LV [9].  In 
our study, we detected clusters of macrophages, located around 
small LV, in CIN III, microcarcinoma and invasive carcinoma. 
Moreover, in all stages named above, we observed CD68+ cells 
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intercalated between LEC.  This macrophage intercalation was 
observed, predominantly, in small and flattened LV (hallmarks 
for young vascular structures) from peritumoral stroma, and 
also in large but invaded vessels.  Our results are consistent 
with data presented by other authors, and support the hypo-
thesis according which integration of macrophage precursors, 
transdifferentiated into LEC, occurs in newly-formed LV. 
We consider this mechanism crucial in the formation of new 
LV because proliferating LV not only enlarge their size and 
become able to support the migration of tumor emboli, but 
also increase the area for targeted action of VEGF-C, secreted 
both by the tumor and stromal cells, via increasing number 
of VEGFR-3 expressing cells in newly-formed LV.
Concluding remarks
Cancer progression represents an extremely sophisticate 
mutual interaction between a variety of molecular agents 
related both to tumor mass and tumor microenvironment. 
From this point of view, macrophages are one of the most 
important sources of a wide spectrum of biologically active 
substances that mediate the tumor progression.
Linear increasing of TAM density during the cervical 
neoplasia progression, their predominant location around 
vascular structures, integration of CD68+ cells into the endo-
thelium of the vessels, demonstrate their crucial importance 
in uterine cervix neoplasia progression.
Based on these findings, we consider that macrophages are 
key regulators of cervical cancer progression.  TAM targeted 
management could be an essential therapeutic strategy, not 
only in order to suppress the progression of cervical neoplasia, 
but also to inhibit macrophage-mediated vascular invasion.
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